Archive for 2018

The 505(b)(2) Drug Patent Approval Process: Uses and Potential Advantages

Drug development is one of the world’s most high-risk / high-reward industries, with the vast majority of drugs created never making it to market. Of those that do make it…
The post The 505(b)(2) Drug Patent Approval Process: Uses and Potential Advanta…


Pharmaceutical Portfolio Management Reading List

Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries This book describes the way that pharmaceutical projects and programs are currently managed, and offers views from many highly…
The post Pharmaceutical Portfo…


How Artificial Intelligence Will Affect Healthcare and Drug Prices

Artificial intelligence (AI) is the development within computer systems of the ability to perform tasks that have traditionally required human intelligence. Examples of AI applications include visual perception, speech recognition,…
The post How Artifi…


Deep Learning in Drug Discovery and Medicine – Scratching the Surface

This paper was originally published by Dibyendu Dana, Satishkumar V. Gadhiya, Luce G. St. Surin, David Li, Farha Naaz, Quaisar Ali, Latha Paka, Michael A. Yamin, Mahesh Narayan, Itzhak D. Goldberg…
The post Deep Learning in Drug Discovery and Medicine …


Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection

This article was originally published by Christopher M. Holman in Intellectual Property Watch under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (http://creativecommons.org/licenses/by-nc-sa/4.0/). Despite the impor…


FDA Approval of New Drugs One of Many Goals for Drug Manufacturers

The US pharmaceutical market, together with those of Canada and Mexico, make more than half the global pharmaceutical. The US alone is the world’s largest and it represents 45 percent of…
The post FDA Approval of New Drugs One of Many Goals for Drug Ma…


Securing the Right Space for Your Biotech Start-up

This is a guest post by Steven Lee, Senior Scientist in the Life Sciences Group at Environmental Health & Engineering (EH&E) Once you have the idea and the funding for a biotech start-up, you may think the biggest challenges are behind you. However, without proper planning and considerations, the environment you choose for your laboratory facility […]


Demystifying Microbiome Probiotics (Supplements)

This is a guest post from Susan K Finston, President of Finston Consulting.  This is the latest entry in an occasional series tracking the microbiome.  I first wrote about the potential of the microbiome for human health in October 2015.  At that time there was little awareness of the significance and potential of the human microbiome.  […]


Evidence of insufficient quality of reporting in patent landscapes in the life sciences

This article was originally published by James A Smith, Zeeshaan Arshad, Hannah Thomas, Andrew J Carr & David A Brindley in Nature Biotechnology v35, pp 210–214 (2017) under a creative…
The post Evidence of insufficient quality of reporting in patent l…


Indian pharmaceutical patent prosecution: The changing role of Section 3(d)

This paper was originally published by Bhaven N. Sampat and Kenneth C. Shadlen in PLoS ONE 13(4): e0194714 under a Creative Commons license. Abstract India, like many developing countries, only recently…
The post Indian pharmaceutical patent prosecutio…


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: